[Perioperative management of orthopaedic patients with hemophilia A]

Zhonghua Wai Ke Za Zhi. 2004 Dec 7;42(23):1430-3.
[Article in Chinese]

Abstract

Objective: To discuss the perioperative management of hemophiliacs A with orthopaedic complications.

Methods: To regulate the injection of factor VIII concentrate in peroperative period by testing the level of factor VIII:C in 27 cases. The lever of factor VIII:C was improved to 30% - 50% at the day before the operation. To the severe patients, it was maintained at 58.5% - 89.3% during the operation and at 47.0% - 78.4% in postoperation. While to the gentle, it was maintained at 38.5% - 52.5% during the operation and at 29.2% - 52.3% in postoperation. The individualized surgical procedures were carried out, such as arthrocentesis, open knee synovectomy or arthroscopic synovectomy, evacuation or curettage of haematoma, debridements, internal fixation.

Results: All patients were cured in 14 - 105 days by regulating the injection of factor VIII during the peroperative period. The usage of factor VIII was 1 200 - 70 250 IU.

Conclusion: While the hemophiliacs have orthopaedic complications, it is necessary to promise the factor VIII:C being maintained at the lever of hemostasis during the peroperative period. The hemophiliacs are endurable to the operation.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Factor VIII / administration & dosage*
  • Fractures, Bone / complications
  • Fractures, Bone / surgery*
  • Hemarthrosis / etiology
  • Hemarthrosis / surgery*
  • Hematoma / etiology
  • Hematoma / surgery
  • Hemophilia A / blood
  • Hemophilia A / complications
  • Hemophilia A / drug therapy*
  • Humans
  • Male
  • Perioperative Care
  • Postoperative Complications / blood

Substances

  • Factor VIII